Global Mycotoxin Testing Market to Reach $1.2 Billion by 2027
Amid the COVID-19 crisis, the global market for Mycotoxin Testing estimated at US$884.9 Million in the year 2020, is projected to reach a revised size of US$1.2 Billion by 2027, growing at aCAGR of 5% over the period 2020-2027. Chromatography
& Spectroscopy-based, one of the segments analyzed in the report, is projected to record 5.6% CAGR and reach US$771.9 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Immunoassay-based segment is readjusted to a revised 4% CAGR for the next 7-year period.
The U.S. Market is Estimated at $239.7 Million, While China is Forecast to Grow at 7.7% CAGR
The Mycotoxin Testing market in the U.S. is estimated at US$239.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$257.4 Million by the year 2027 trailing a CAGR of 7.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.7% and 4.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.We bring years of research experience to this 6th edition of our report. The 262-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.Competitors identified in this market include, among others,
- ALS Ltd.
- AsureQuality Ltd.
- Bureau Veritas SA
- Eurofins Scientific SE
- Intertek Group PLC
- Microbac Laboratories, Inc.
- Romer Labs Division Holding GmbH
- SGS SA
- Silliker, Inc.
- Symbio Laboratories